Opendata, web and dolomites

CRISPR-GQ SIGNED

Identifying the Capabilities and Limitations of CRISPR in Targeting G-quadruplex Forming Sequences: From Target Recognition to Gene Expression Regulation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CRISPR-GQ project word cloud

Explore the words cloud of the CRISPR-GQ project. It provides you a very rough idea of what is the project "CRISPR-GQ" about.

prevent    quadruplex    concentration    single    telomeric    expression    werner    stabilizing    suggested    tyrosine    dementia    guide    constructs    promoters    underway    course    bloom    palindromic    cas    forming    strand    editing    genes    molecule    form    promoter    wish    amyotrophic    sites    genome    untranslated    enormous    dna    techniques    absence    secondary    translation    rna    gq    syndromes    interspaced    gene    lateral    transcription    als    regulation    variants    limitations    demonstrated    inhibit    disorders    elucidate    pqs    frontotemporal    pursue    neurological    regulatory    precision    region    clustered    critical    molecules    small    ftd    regions    perform    canonical    crispr    structure    potentially    sclerosis    bulk    inability    cells    specificity    oncogenes    hydroxylase    cas9    world    frequency    vicinity    regulate    structures    certain    human    geared    therapeutic    assays    forefront    genomic    sequences    myc    effort    proteins    complementary    remove   

Project "CRISPR-GQ" data sheet

The following table provides information about the project.

Coordinator
TECHNISCHE UNIVERSITEIT DELFT 

Organization address
address: STEVINWEG 1
city: DELFT
postcode: 2628 CN
website: www.tudelft.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website https://sites.google.com/site/balcilab/research/mariecuriefellowshipreport
 Total cost 88˙799 €
 EC max contribution 88˙799 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-07-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNISCHE UNIVERSITEIT DELFT NL (DELFT) coordinator 88˙799.00

Map

 Project objective

Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated proteins (Cas) have recently been at the forefront of genomic research due to their enormous potential at editing the genome with great precision and specificity. A world-wide effort is currently underway to test Cas proteins and their variants for applications geared towards genome editing for human cells. How CRISPR-Cas systems perform in editing sequences that form non-canonical DNA or RNA secondary structures or are in the vicinity of such structures is the problem we wish to pursue during the course of proposed studies. One such structure is the G-quadruplex (GQ), which has been demonstrated to form throughout the human genome, with particular concentration in telomeric sites, promoters, and 3’ and 5’ untranslated regions of RNA. The higher frequency of potentially GQ forming sequences (PQS) at such regulatory sites has suggested a potential role for these structures in transcription or translation level gene expression regulation. GQ formation has been demonstrated to inhibit gene expression for a number of different genes, including certain critical oncogenes. Inability to remove these structures is directly associated with several syndromes, including Bloom and Werner syndromes, and neurological disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Therefore, editing such sequences to prevent GQ formation also has therapeutic potential. We will design different single guide RNA constructs and target the GQ forming G-rich or the complementary C-rich strand to elucidate the capabilities and limitations of the CRISPR-Cas9 system in editing such structures using single molecule techniques and bulk assays. We will then investigate whether CRISPR-Cas9 can be used to regulate gene expression by targeting GQ structures in the promoter region of tyrosine hydroxylase and c-Myc genes in the presence and absence of GQ stabilizing small molecules.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CRISPR-GQ" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CRISPR-GQ" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

IRF4 Degradation (2019)

Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells

Read More  

signalling dynamics (2020)

Bridging biophysics and cell biology: The role of G protein-coupled receptor conformations in signalling

Read More  

MAGIMOX (2019)

Nanometre scale imaging of magnetic perovskite oxide thin films using scanning transmission electron microscopy

Read More